Anticancer Drug Discovery and Development

Dear Colleagues,

Cancer is a world health issue and affects all communities around the globe and this disease is the second leading cause of death globally. Moreover, there has been continued progress in anticancer drug development in the last few years. New anticancer agents have been approved for cancer treatment but majority of these approved molecules have serious adverse side effects. This illustrates that there is still an urgent need for the development of novel anti-cancer drugs with a unique mechanism of action.

The focus of this Topical Collection is on Natural products (NPs)-based anticancer molecules, and synthetic anticancer compounds. Notably, this Topical Collection will also emphasis on the relationship between the chemical structure and the biological activity of the molecules along with appplication of bioinformatics in cancers. Furthermore, this Topical Collection also wellcome articles anticancer effects as vascular targeting agents, tubulin inhibitors, and topoisomerase targeting agents. In addition, this Topical Collection will also focus on the development of new therapeutic agents for cancer treatment, employing the newest techniques of pharmacology, biotechnology, and genetic engineering. This Topical Collection welcomes original articles, communications and reviews dealing with the cancer treatment.

Dr. Hidayat Hussain
Collection Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.